Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?

Radiotherapy and Oncology

Volumn 71, Issue 2, 2004, Pages 123-125

  Jeremic, Branislav ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

BRONCHOSCOPY; EDITORIAL; HISTOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOSENSITIVITY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MALE; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 1942478538     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.11.009     Document Type: Editorial

References (28)

1. Belderbos J.S.A., De Jaeger K., Heemsbergen W.D., et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol. 66:2003;119-126.
2. Bradley J.D., Wahab S., Lockett M.A., Perez C.A., Purdy J.A. Elective nodal failures are uncommon in medically inoperable patients with stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys. 56:2003;342-347.
3. Bush D.A., Slater J.D., Bonnet R., et al. Proton-beam radiotherapy for early-stage lung cancer. Chest. 116:1999;1313-1319.
4. Chen Z.L., Perez S., Cochran A.J., et al. Frequency and distribution of occult micrometastasis in lymph nodes of patients with non-small cell lung carcinoma. J Natl Cancer Inst. 85:1993;493-498.
5. Conces D.J. Jr., Klink J.F., Tarver R.D., Moak G.D. T1N0M0 lung cancer: evaluation with CT. Radiology. 170:1989;643-646.
6. Ginsberg R.J., Rubinstein L., for the Lung Cancer Study Group. A randomised study of lobectomy versus limited resection for patients with T1N0 non-small cell lung cancer. Ann Thorac Surg. 60:1995;908-913.
7. Heavey L.R., Glazer G.M., Gross B.H., Frances I.R., Orringer M.B. The role of CT in staging radiographic T1N0M0 lung cancer. Am J Roentgenol. 146:1986;285-290.
8. Ishida T., Yano T., Maeda K. Strategy for lymphadenopathy in lung cancer 3 cm or less in diameter. Ann Thorac Surg. 50:1991;708-771.
9. Jeremic B., Shibamoto Y., Acimovic L.J., Milisavljevic S. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 38:1997;521-525.
10. Jeremic B., Shibamoto Y., Acimovic L.J., Milisavljevic S. Hyperfractionated radiotherapy for clinical stage II nonsmall cell lung cancer. Radiother Oncol. 51:1999;141-145.
11. Jeremic B., Classen J., Bamberg M. Radiation therapy alone in technically operable, medically inoperable early stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 54:2002;119-130.
12. Koto M., Miyamoto T., Yamamoto N., Nishimira H., Yamada S., Tsujii H. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol. 71:2004;147-156.
13. Krol A.D.G., Aussems P., Noordijk E.M., Hermans J., Leer J.W. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys. 34:1996;297-302.
14. Lagerwaard F.J., Senan S., van Meerbeck J.P., Graveland W.J., Rotterdam Oncological Thoracic Study Group. Has 3-D conformal radiotherapy (3D-CRT) improved local tumour control for stage I non-small cell lung cancer? Radiother Oncol. 63:2002;151-157.
15. MacManus M.P., Hicks R.J., Matthews J.P., et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical therapy. Int J Radiat Oncol Biol Phys. 50:2001;287-294.
16. Martel M.K., Sahijdak W.M., Hayman J.A., Ball D. Incidental dose to clinically negative nodes from conformal treatment fields for nonsmall cell lung cancer (Abstract). Int J Radiat Oncol Biol Phys. 45:(3S):1999;244.
17. Maruyama R., Sugio K., Mitsudomi T., Saitoh G., Ishida T., Sugimachi K. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 114:1997;535-543.
18. Miyamoto T., Yamamoto N., Nishimira H., et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol. 66:2003;127-140.
19. Naruke T., Goya T., Tsuchiya R., Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 96:1988;440-447.
20. Noordijk E.M., vd Poest Clement E., Hermans J., Wever A.M., Leer J.W. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol. 13:1988;83-89.
21. Rosenzweig K.E., Sim S.E., Mychalczak B., Braban L.E., Schindelheim R., Leibel S.A. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 50:2001;681-685.
22. Sawyer T.E., Bonner J.A., Gould P.M., et al. Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer. Implications in the inoperable and three-dimensional dose-escalation settings. Int J Radiat Oncol Biol Phys. 43:1999;965-970.
23. Slotman B.J., Karim A.B.M.F. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 29:1994;33-37.
24. Senan S., Burgers S., Samson M.J., et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys. 2002;999-1006.
25. Suzuki K., Nagai K., Yoshida J., Nishimura M., Nishiwaki Y. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg. 72:2001;352-356.
26. Suzuki K., Nagai K., Yoshida J., Nishimura M., Takahashi K., Nishiwaki Y. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg. 117:1999;593-598.
27. Takizawa T., Terashima M., Koike T., et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg. 116:1998;276-280.
28. Zhang H.X., Yin W.B., Zhang L.J., et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol. 14:1989;89-94.